Skip to main content

Table 3 Visibility and feasibility results of CEUS-CT/MR FI for inconspicuous tumors

From: Contrast-enhanced ultrasonography–CT/MRI fusion guidance for percutaneous ablation of inconspicuous, small liver tumors: improving feasibility and therapeutic outcome

 

Visibility score 3 or 4

Feasibility score 3 or 4

p-value

Total

220/248 (88.7)

235/248 (94.8)

< 0.001

By location (binominal)

  

< 0.001

Left lobe

57/62 (91.9)

59/62 (95.2)

 

Right superior segments

84/99 (84.8)

91/99 (91.9)

 

Right inferior segments

79/87 (90.8)

85/87 (97.7)

 

By size (binominal)

  

< 0.001

< 2 cm

142/168 (84.5)

156/168 (92.9)

 

≥ 2 cm, < 2.5 cm

62/64 (96.9)

63/64 (98.4)

 

≥ 2.5 cm

16/16 (100)

16/16 (100)

 

By contrast agent (binominal)

  

< 0.001

SonoVue

121/138 (87.7)

130/138 (94.2)

 

Sonazoid

99/110 (90.0)

105/110 (95.5)

 
  1. Note: Unless indicated, data are number of tumors, with the percentage in parentheses